StockPriceToday
Analog Devices Inc (ADI)
About Analog Devices Inc
Analog Devices Inc. designs, manufactures, and markets integrated circuits and signal processing solutions that convert, condition, and process real-world phenomena such as light, sound, temperature, and motion into electrical signals. The company's essential components make ADI stock price sensitive to industrial automation, automotive, and communications market trends.
ADI's products enable various applications including industrial automation, automotive systems, communications infrastructure, healthcare equipment, and consumer electronics. The company's high-performance analog and mixed-signal technologies provide critical functionality in complex electronic systems.
The company's focus on automotive electrification, 5G communications, and industrial IoT applications positions it well for emerging technology trends. ADI's acquisition strategy and research investments enhance its technology portfolio and market reach, affecting ADI stock price performance.
ADI's engineering expertise and customer relationships provide competitive advantages while its diverse end-market exposure reduces dependence on any single industry. The company's ability to develop innovative solutions while maintaining technology leadership remains important for its continued growth and market positioning.
ADI Stock 12 Month Chart
Latest News for ADI
Analog Devices, Inc. (NASDAQ:ADI) is one of the 10 Best American Stocks to Buy and Hold for the Next Decade. On May 26, 2026, JPMorgan raised the firm’s price target on Analog Devices, Inc.
With a market cap of $201.6 billion, Analog Devices, Inc. (ADI) is a leading semiconductor company that designs, manufactures, and markets integrated circuits (ICs), software, and subsystem products ...
On May 26, Argus raised its price target on Analog Devices Inc (NASDAQ:ADI) shares to $460 from $400 and kept a Buy rating on the stock.
Other Popular Stocks
Arcutis Biotherapeutics Inc. is a biotechnology company developing topical therapies for dermatological conditions.
Myriad Genetics Inc. (MYGN) is a genetic testing company providing molecular diagnostic tests for cancer risk assessment, treatment selection, and personalized medicine applications.
Leonardo DRS Inc. (DRS) is a leading provider of defense technology solutions and systems integration services, serving U.S. and allied military customers with advanced...